Press releases

Part of Sanitas employees will be motivated by company’s shares

Press release

19.06.2008

Part of the employees of Sanitas, the largest pharmaceutical company in , and part of employees of pharmaceutical plant Hoechst-Biotika and the Polish pharmaceutical producer Jelfa, both controlled by Sanitas, will have an opportunity to acquire shares of Sanitas. During the Sanitas General Shareholders Meeting which will take place on Ju ly 2 it will be suggested to issue additional LTL 750 thousand shares emission, emission price of the one share LTL 16, and allow the employees of the company to acquire these shares. The list of the employees having the right to acquire these shares will be approved by the Sanitas Management Board.

After the full distribution of the new shares emission, the total amount of which is LTL 12 million, the authorized capital of Sanitas would increase to 31 855 920.

According to Darius Sulnis, the chairman of Sanitas Management Board, the shareholders of the company clear ly expressed their readiness to share created value with the employees and promote they participation in the capital of the company by approving Stock Option Plan in 2007.

“We have to take into account that review of Sanitas strategic alternatives is being performed and possibilities to increase company‘s value are being ana ly sed, after which certain offers may be given to the shareholders. For this reason the issuance of emission would be time ly and would realize the settlement between the shareholders and company‘s management“, - explained D. Sulnis.

Investment company Invalda as well as investment funds Amber Trust II SCA and Citigroup Venture Capital International Jersey are the main shareholders of Sanitas. Sanitas’ shares are quoted on the Main List of the Vilnius Stock Exchange.

For more information please contact:

Darius Sulnis, the chairman of Sanitas Management Board, mob. tel. +370 698 34781